Globus Medical Releases New LLIF Device

Globus Medical Inc., a musculoskeletal implant manufacturer, has introduced Rise-L, a lateral lumbar interbody fusion (LLIF) device and the latest addition to the company’s portfolio of expandable spacers.

The LLIF procedure, approaching the spine from the side of the patient, allows for a larger implant footprint, and is less disruptive to lower back muscles as compared other approaches, which may result in less blood loss and faster recovery.

Rise-L is a vertically expanding LLIF device designed to minimize impaction, maximize indirect decompression, and provide a large graft space optimal for fusion potential. The all-titanium implant is designed for up to 7 mm of continuous in situ expansion and to provide restorative disc height with proper anatomical fit. Available in multiple sizes, in parallel or lordotic profiles, Rise-L is meant to provide options for surgeons to address proper sagittal balance. A large single graft chamber can be filled with autogenous bone graft material after insertion and expansion to ensure even contact with both vertebral endplates, the company reports.

“Over the last four years we have continued to build upon our unmatched family of expandable spacers, and I am proud of our product development team with the launch of Rise-L,” said Andrew Iott, senior vice president of product development. “This new lateral cage eliminates the need to forcefully impact the cage into the disc space. Our expansion technology allows the Rise-L cage to be placed in compact form, and expanded for optimal fit, and also includes a large port for easy graft delivery once expanded.”

“Having used Rise-L, I am encouraged by the results in my patients,” Kevin S. Cahill, M.D., Ph.D., MPH, spinal neurosurgeon at Carolina Neurosurgery & Spine Associates in Charlotte, N.C. “This novel expandable cage addresses many issues with lumbar fusion devices on the market today. With all the benefits of the lateral approach as well as gentle cage insertion, in situ expandability, and robust lordotic options, Rise-L offers a customized fit and less endplate disturbance. The implant has a graft chamber that is comparable to non-expandable cages as well as a large backfilling port for inserting additional graft material after expansion. Rise-L is the most elegant solution for lateral interbody fusion on the market.”

The Rise spacer is a lumbar interbody fusion device intended for use in patients with degenerative disc disease (DDD) at one or two contiguous levels of the lumbosacral spine (L2-S1). DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. The device’s indication is for skeletally mature patients who and have had at least six months of non-operative treatment. In addition, these patients may have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). The Rise spacer is to be filled with autogenous bone graft material, and is intended for use with supplemental fixation.